Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Current Deferred Revenue (2024 - 2025)

Rallybio's Current Deferred Revenue history spans 2 years, with the latest figure at $424000.0 for Q3 2025.

  • For Q3 2025, Current Deferred Revenue fell 61.35% year-over-year to $424000.0; the TTM value through Sep 2025 reached $424000.0, down 61.35%, while the annual FY2024 figure was $848000.0, N/A changed from the prior year.
  • Current Deferred Revenue for Q3 2025 was $424000.0 at Rallybio, down from $636000.0 in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $1.2 million in Q2 2024 and bottomed at $424000.0 in Q3 2025.